Pentylone

From Wikipedia, the free encyclopedia

Jump to: navigation, search
Pentylone
Pentylone.svg
Systematic (IUPAC) name
(±)-1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one
Clinical data
Legal status
Legal status
Identifiers
CAS Number 698963-77-8 YesY
17763-01-8 (hydrochloride)
ATC code none
PubChem CID 60208608
ChemSpider 29786041 N
Chemical data
Formula C13H17NO3
Molar mass 235.278 g/mol
 NYesY (what is this?)  (verify)

β-Keto-Methylbenzodioxolylpentanamine (Pentylone, βk-Methyl-K, βk-MBDP, methylenedioxypentedrone) is a stimulant compound developed in the 1960s,[1] which has been reported as a novel designer drug and identified in some samples of powders sold as "NRG-1", along with varying blends of other substituted cathinone derivatives including flephedrone, MDPBP, MDPV and 4-MePPP. It was also found in combination with 4-MePPP being sold as "NRG-3".[2]

Pharmacology[edit]

Pentylone acts as a serotonin-norepinephrine-dopamine reuptake inhibitor and weak serotonin releasing agent.[3]

Legality[edit]

Pentylone is an Anlage II controlled substance in Germany.

It is also illegal in Sweden.[4]

Pentylone is a Schedule I controlled drug in the US.[5]

See also[edit]

References[edit]

  1. ^ Substituted phenyl-α-amino ketones. British Patent GB 1085135 (1969).
  2. ^ Brandt SD, Freeman S, Sumnall HR, Measham F, Cole J (December 2010). "Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones". Drug Testing and Analysis 3 (9): 569–75. doi:10.1002/dta.204. PMID 21960541. 
  3. ^ Simmler, L. D.; Rickli, A.; Hoener, M. C.; Liechti, M. E. (2014). "Monoamine transporter and receptor interaction profiles of a new series of designer cathinones". Neuropharmacology 79: 152–60. doi:10.1016/j.neuropharm.2013.11.008. PMID 24275046. 
  4. ^ "Cannabinoider föreslås bli klassade som hälsofarlig vara" (in Swedish). Retrieved 29 June 2015. 
  5. ^ Schedules of Controlled Substances: Temporary Placement of 10 Synthetic Cathinones Into Schedule I